 |
|
prostatic acid phosphatase-sargramostim fusion protein
A genetically-engineered protein formed by the fusion of prostatic acid phosphatase (PAP) and sargramostim (GM-CSF). Vaccination with antigen-presenting cells (APC) loaded with prostatic acid phosphatase-sargramostim fusion protein may elicit a cytotoxic T-cell response against tumor cells that express PAP. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Code name: | | PA2024 | | |
|
|
